Your browser doesn't support javascript.
loading
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Kotsia, Anna; Brilakis, Emmanouil S; Held, Claes; Cannon, Christopher; Steg, Gabriel P; Meier, Bernhard; Cools, Frank; Claeys, Marc J; Cornel, Jan H; Aylward, Philip; Lewis, Basil S; Weaver, Douglas; Brandrup-Wognsen, Gunnar; Stevens, Susanna R; Himmelmann, Anders; Wallentin, Lars; James, Stefan K.
Afiliação
  • Kotsia A; VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX.
  • Brilakis ES; VA North Texas Healthcare System and UT Southwestern Medical Center, Dallas, TX. Electronic address: esbrilakis@yahoo.com.
  • Held C; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Cannon C; Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  • Steg GP; INSERM-Unité 698, Paris, France; Assistance Publique-Hôpitaux de Paris, Département Hospitalo-Universitaire FIRE, Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne-Paris Cité, Paris, France; NHLI Imperial College, ICMS, Royal Brompton Hospital, London, United Kingdom.
  • Meier B; Bern University Hospital, Bern, Switzerland.
  • Cools F; AZ KLINA, Brasschaat, Antwerp, Belgium.
  • Claeys MJ; University Hospital Antwerp, Antwerp, Belgium.
  • Cornel JH; Department of cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.
  • Aylward P; South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide, Australia.
  • Lewis BS; Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-ITT, Haifa, Israel.
  • Weaver D; Henry Ford Heart and Vascular Institute, Detroit, MI.
  • Brandrup-Wognsen G; AstraZeneca Research and Development, Mölndal, Sweden.
  • Stevens SR; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
  • Himmelmann A; AstraZeneca Research and Development, Mölndal, Sweden.
  • Wallentin L; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • James SK; Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Am Heart J ; 168(1): 68-75.e2, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24952862
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Adenosina / Síndrome Coronariana Aguda Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Adenosina / Síndrome Coronariana Aguda Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am Heart J Ano de publicação: 2014 Tipo de documento: Article